㈜니오테스바이오

{
  "address": "경기도 성남시",
  "ceo_name": "KIM YONG IN",
  "certificate": [
    {
      "cert_number": "20210300128",
      "changes": "",
      "disclosure_date": "2021-01-28",
      "first_cert_date": "2021-01-28",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2021-01-28 ~ 2023-01-27"
    },
    {
      "cert_number": "20230308010041",
      "changes": "",
      "disclosure_date": "2023-03-08",
      "first_cert_date": "2021-01-28",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2023-01-28 ~ 2026-01-27"
    },
    {
      "cert_number": "20251223010071",
      "changes": "",
      "disclosure_date": "2025-12-23",
      "first_cert_date": "2021-01-28",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2026-01-28 ~ 2029-01-27"
    }
  ],
  "company_name": "㈜니오테스바이오",
  "corp_no": "131111-*******",
  "financials": {
    "2022": {
      "capital_stock": 246813000,
      "cost_of_sales": 0,
      "current_assets": 609679000,
      "current_liabilities": 15965000,
      "gross_profit": 0,
      "net_income": -912309000,
      "net_income_bs": -912309000,
      "non_current_assets": 113466000,
      "non_current_liabilities": 844000,
      "non_operating_expenses": 126000,
      "non_operating_income": 14286000,
      "operating_profit": -926469000,
      "revenue": 0,
      "sga_expenses": 926469000,
      "total_assets": 723145000,
      "total_equity": 706336000,
      "total_liabilities": 16809000
    },
    "2023": {
      "capital_stock": 246813000,
      "cost_of_sales": 0,
      "current_assets": 1042625000,
      "current_liabilities": 19133000,
      "gross_profit": 0,
      "net_income": -595693000,
      "net_income_bs": -595693000,
      "non_current_assets": 87151000,
      "non_current_liabilities": 1000000000,
      "non_operating_expenses": 11469000,
      "non_operating_income": 13806000,
      "operating_profit": -598030000,
      "revenue": 0,
      "sga_expenses": 598030000,
      "total_assets": 1129776000,
      "total_equity": 110643000,
      "total_liabilities": 1019133000
    },
    "2024": {
      "capital_stock": 246813000,
      "cost_of_sales": 0,
      "current_assets": 426812000,
      "current_liabilities": 14222000,
      "gross_profit": 0,
      "net_income": -625592000,
      "net_income_bs": -625592000,
      "non_current_assets": 72461000,
      "non_current_liabilities": 1000000000,
      "non_operating_expenses": 49398000,
      "non_operating_income": 16317000,
      "operating_profit": -592511000,
      "revenue": 0,
      "sga_expenses": 592511000,
      "total_assets": 499273000,
      "total_equity": -514949000,
      "total_liabilities": 1014222000
    }
  },
  "industry": "그 외 기타 분류 안된 화학제품 제조업",
  "investment": [
    {
      "amount": "100,000,000",
      "changes": "100,000,000",
      "date": "2021-05-24"
    },
    {
      "amount": "100,000,000",
      "changes": "100,000,000",
      "date": "2021-05-24"
    },
    {
      "amount": "100,000,000",
      "changes": "100,000,000",
      "date": "2021-05-24"
    },
    {
      "amount": "100,000,000",
      "changes": "100,000,000",
      "date": "2021-05-24"
    },
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2020-12-23"
    },
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2020-12-23"
    }
  ],
  "main_products": "신약 개발",
  "phone": "070-4570-****",
  "years": [
    2024,
    2023,
    2022
  ]
}